Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
INVA Innoviva Inc
- Stocks
- Healthcare
- NASDAQ: INVA
Price (delayed)
$18.58
Market cap
$1.17B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.95
Enterprise value
$1.3B
Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.
Highlights
The gross profit is up by 26% YoY and by 2.1% from the previous quarter
The revenue has grown by 19% YoY and by 3.1% from the previous quarter
Innoviva's quick ratio has plunged by 74% YoY but it has increased by 6% from the previous quarter
The company's EPS has shrunk by 134% YoY
INVA's net income has dropped by 133% year-on-year
Key stats
What are the main financial stats of INVA
Market
Valuations
Earnings
Shares outstanding
62.78M
Market cap
$1.17B
Enterprise value
$1.3B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.8
Price to sales (P/S)
3.15
EV/EBIT
N/A
EV/EBITDA
88.72
EV/Sales
3.5
Revenue
$369.84M
Gross profit
$328.9M
Operating income
$180.73M
Net income
-$59.72M
EBIT
-$25.26M
EBITDA
$14.61M
Free cash flow
$195.99M
Per share
Balance sheet
Liquidity
EPS
-$0.95
EPS diluted
-$0.96
Free cash flow per share
$3.13
Book value per share
$10.32
Revenue per share
$5.9
TBVPS
$16.5
Total assets
$1.25B
Total liabilities
$607.49M
Debt
$448.89M
Equity
$646.91M
Working capital
$347.28M
Debt to equity
0.69
Current ratio
2.48
Quick ratio
2.24
Net debt/EBITDA
8.88
Margins
Efficiency
Dividend
EBITDA margin
4%
Gross margin
88.9%
Net margin
-16.1%
Operating margin
48.9%
Return on assets
-4.8%
Return on equity
-8.9%
Return on invested capital
-2.5%
Return on capital employed
-2.5%
Return on sales
-6.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INVA stock price
How has the Innoviva stock price performed over time
Intraday
-0.85%
1 week
-0.38%
1 month
7.71%
1 year
19.41%
YTD
7.09%
QTD
2.48%
Financial performance
How have Innoviva's revenue and profit performed over time
Revenue
$369.84M
Gross profit
$328.9M
Operating income
$180.73M
Net income
-$59.72M
Gross margin
88.9%
Net margin
-16.1%
INVA's net income has dropped by 133% year-on-year
The net margin has plunged by 128% YoY
INVA's operating income has soared by 70% YoY and by 10% QoQ
The operating margin has increased by 43% YoY and by 7% from the previous quarter
Price vs fundamentals
How does INVA's price correlate with its fundamentals
Growth
What is Innoviva's growth rate over time
Valuation
What is Innoviva stock price valuation
P/E
N/A
P/B
1.8
P/S
3.15
EV/EBIT
N/A
EV/EBITDA
88.72
EV/Sales
3.5
The company's EPS has shrunk by 134% YoY
The P/B is 14% below the 5-year quarterly average of 2.1 but 6% above the last 4 quarters average of 1.7
The equity has declined by 8% year-on-year and by 6% since the previous quarter
The revenue has grown by 19% YoY and by 3.1% from the previous quarter
Efficiency
How efficient is Innoviva business performance
The return on invested capital has dropped by 146% since the previous quarter and by 114% year-on-year
The company's return on sales has shrunk by 141% QoQ and by 110% YoY
INVA's ROA has plunged by 132% YoY
INVA's return on equity has dropped by 131% year-on-year
Dividends
What is INVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INVA.
Financial health
How did Innoviva financials performed over time
The total assets is 106% greater than the total liabilities
The company's current ratio has shrunk by 76% YoY but it rose by 6% QoQ
Innoviva's quick ratio has plunged by 74% YoY but it has increased by 6% from the previous quarter
The debt is 31% less than the equity
The debt to equity has grown by 10% year-on-year and by 6% since the previous quarter
The equity has declined by 8% year-on-year and by 6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.